Purchases and Sales Made in Q2 2023 in Lexicon Pharmaceuticals, Inc. (LXRX)
This table provides information about the institutional ownership of Lexicon Pharmaceuticals, Inc. (LXRX) during Q2 2023. The information is specifically focused on institutions that hold shares of LEXICON PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-48.2K- 30.8% |
$104K - $168K
|
108K
$83.5K
|
|
|
Aug 10, 2023
Q2 2023
|
Great West Life Assurance CO
Winnipeg, A2 |
SELL
|
- |
-49.5K- 91.44% |
$107K - $173K
|
4.64K
$3.57K
|
|
|
Aug 11, 2023
Q2 2023
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-49.6K- 49.03% |
$107K - $173K
|
51.6K
$39.7K
|
|
|
Aug 08, 2023
Q2 2023
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
SELL
|
- |
-197K- 27.33% |
$423K - $687K
|
523K
$403K
|
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-375K- 11.34% |
$806K - $1.31M
|
2.93M
$2.26M
|
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-1.73M- 58.73% |
$3.71M - $6.03M
|
1.21M
$935K
|